Your search returned 26 results.

Results
	1.	Development of Human Target Validation Classification that Predicts Future Clinical Efficacy. [electronic resource] by Karlsson, Cecilia Greasley, Peter J Gustafsson, David Wåhlander, Karin Producer: 20191104 In: The Journal of pharmacology and experimental therapeutics vol. 368 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	No effect of encapsulation on the pharmacokinetics of warfarin. [electronic resource] by Johansson, Susanne Ohlsson, Lis Stenhoff, Helene Wåhlander, Karin Cullberg, Marie Producer: 20050711 In: Biopharmaceutics & drug disposition vol. 26 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Trousseau's syndrome - what is the evidence? A population-based autopsy study. [electronic resource] by Ogren, Mats Bergqvist, David Wåhlander, Karin Eriksson, Henry Sternby, Nils H Producer: 20060427 In: Thrombosis and haemostasis vol. 95 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Prognostic factors for recurrence of venous thromboembolism (VTE) or bleeding during long-term secondary prevention of VTE with ximelagatran. [electronic resource] by Eriksson, Henry Lundström, Torbjörn Wåhlander, Karin Clason, Solveig Billing Schulman, Sam Producer: 20060606 In: Thrombosis and haemostasis vol. 94 Availability: No items available. Save to lists Add to cart (remove)
	5.	Secondary prevention of venous thromboembolism with the oral direct thrombin inhibitor ximelagatran. [electronic resource] by Schulman, Sam Wåhlander, Karin Lundström, Torbjörn Clason, Solveig Billing Eriksson, Henry Producer: 20031105 In: The New England journal of medicine vol. 349 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	No influence of mild-to-moderate hepatic impairment on the pharmacokinetics and pharmacodynamics of ximelagatran, an oral direct thrombin inhibitor. [electronic resource] by Wåhlander, Karin Eriksson-Lepkowska, Maria Frison, Lars Fager, Gunnar Eriksson, Ulf G Producer: 20040106 In: Clinical pharmacokinetics vol. 42 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Effects of IL-1beta and IL-6 on tissue-type plasminogen activator expression in vascular endothelial cells. [electronic resource] by Larsson, Pia Ulfhammer, Erik Karlsson, Lena Bokarewa, Maria Wåhlander, Karin Jern, Sverker Producer: 20090312 In: Thrombosis research vol. 123 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Reversible elevations of serum creatinine levels but no effect on glomerular filtration during treatment with the direct thrombin inhibitor AZD0837. [electronic resource] by Schützer, Kajs-Marie Svensson, Maria K Zetterstrand, Sofia Eriksson, Ulf G Wåhlander, Karin Producer: 20101112 In: European journal of clinical pharmacology vol. 66 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Pharmacokinetics and anticoagulant effect of the direct thrombin inhibitor melagatran following subcutaneous administration to healthy young men. [electronic resource] by Johansson, Susanne Wåhlander, Karin Larson, Göran Ohlsson, Lis Larsson, Marita Eriksson, Ulf G Producer: 20040708 In: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Consistent pharmacokinetics of the oral direct thrombin inhibitor ximelagatran in patients with nonvalvular atrial fibrillation and in healthy subjects. [electronic resource] by Wolzt, Michael Wollbratt, Maria Svensson, Mia Wåhlander, Karin Grind, Margaretha Eriksson, Ulf G Producer: 20040206 In: European journal of clinical pharmacology vol. 59 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	Effects of the oral direct thrombin inhibitor ximelagatran on p-selectin expression and thrombin generation in atrial fibrillation. [electronic resource] by Wolzt, Michael Boström, Stig L Svensson, Mia Wåhlander, Karin Grind, Margaretha Sarich, Troy C Producer: 20040805 In: Pathophysiology of haemostasis and thrombosis vol. 33 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	12.	Pharmacokinetics of ximelagatran and relationship to clinical response in acute deep vein thrombosis. [electronic resource] by Cullberg, Marie Eriksson, Ulf G Wåhlander, Karin Eriksson, Henry Schulman, Sam Karlsson, Mats O Producer: 20050602 In: Clinical pharmacology and therapeutics vol. 77 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	13.	Histone deacetylase inhibitors stimulate tissue-type plasminogen activator production in vascular endothelial cells. [electronic resource] by Larsson, Pia Bergh, Niklas Lu, Emma Ulfhammer, Erik Magnusson, Mia Wåhlander, Karin Karlsson, Lena Jern, Sverker Producer: 20131017 In: Journal of thrombosis and thrombolysis vol. 35 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	14.	Safety and tolerability of an immediate-release formulation of theoral direct thrombin inhibitor AZD0837 in the prevention of stroke and systemic embolism in patients with atrial fibrillation. [electronic resource] by Olsson, S Bertil Rasmussen, Lars H Tveit, Arnljot Jensen, Eva Wessman, Peter Panfilov, Seva Wåhlander, Karin Producer: 20100824 In: Thrombosis and haemostasis vol. 103 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	15.	Pharmacokinetics, pharmacodynamics and clinical effects of the oral direct thrombin inhibitor ximelagatran in acute treatment of patients with pulmonary embolism and deep vein thrombosis. [electronic resource] by Wåhlander, Karin Lapidus, Leif Olsson, Carl-Gustav Thuresson, Anneli Eriksson, Ulf G Larson, Göran Eriksson, Henry Producer: 20031010 In: Thrombosis research vol. 107 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	16.	Risk of recurrent venous thromboembolism or bleeding in relation to thrombophilic risk factors in patients receiving ximelagatran or placebo for long-term secondary prevention of venous thromboembolism. [electronic resource] by Wåhlander, Karin Eriksson, Henry Lundström, Torbjörn Billing Clason, Solveig Wall, Ulrika Nyström, Per Wessman, Peter Schulman, Sam Producer: 20060503 In: British journal of haematology vol. 133 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	17.	Effects of AZD0837, a novel direct thrombin inhibitor, on the electrophysiological properties of the human heart: a randomized, double-blind, parallel-group, placebo-controlled study. [electronic resource] by Walfridsson, Håkan Johansson, Birgitta Englund, Anders Kennebäck, Göran Schwieler, Jonas Kongstad, Ole Wåhlander, Karin Malm, Anders R Edvardsson, Nils Producer: 20100816 In: Clinical drug investigation vol. 30 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	18.	Exposure-response for biomarkers of anticoagulant effects by the oral direct thrombin inhibitor AZD0837 in patients with atrial fibrillation. [electronic resource] by Lip, Gregory Y H Rasmussen, Lars H Olsson, S Bertil Jensen, Eva Hamrén, Bengt Eriksson, Ulf G Wåhlander, Karin Producer: 20160929 In: British journal of clinical pharmacology vol. 80 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	19.	Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: a randomized dose-guiding, safety, and tolerability study of four doses of AZD0837 vs. vitamin K antagonists. [electronic resource] by Lip, Gregory Y H Rasmussen, Lars H Olsson, S Bertil Jensen, Eva C Persson, Anders L Eriksson, Ulf Wåhlander, Karin F C Producer: 20100330 In: European heart journal vol. 30 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	20.	Antithrombotic effects of ximelagatran plus acetylsalicylic acid (ASA) and clopidogrel plus ASA in a human ex vivo arterial thrombosis model. [electronic resource] by Wåhlander, Karin Eriksson-Lepkowska, Maria Nyström, Per Eriksson, Ulf G Sarich, Troy C Badimon, Juan J Kalies, Inge Elg, Margareta Bylock, Anders Producer: 20060427 In: Thrombosis and haemostasis vol. 95 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search

Availability

Authors

Topics

Languages

Your search returned 26 results.